Recent Finacing
Recent Raise
Carmell Therapeutics develops plasma-derived bioactive materials from human blood plasma that form resorbable putties, pastes, scaffolds and implants to deliver native regenerative factors for bone and tendon healing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors